|
| 36221864 | WHO 2022 classification of penile and scrotal cancers: updates and evolution. | Histopathology | 2023 |
| 36221864 | WHO 2022 classification of penile and scrotal cancers: updates and evolution. | Histopathology | 2023 |
| 36202687 | Prostate Adenocarcinoma Grade Group 1: Rationale for Retaining a Cancer Label in the 2022 World Health Organization Classification. | Eur Urol | 2023 |
| 36198279 | Matrix-Assisted Laser Desorption/Ionization Mass Spectrometry Imaging: Diagnostic Pathways and Metabolites for Renal Tumor Entities. | Oncology | 2023 |
| 37653120 | Multielement Z-tag imaging by X-ray fluorescence microscopy for next-generation multiplex imaging. | Nat Methods | 2023 |
| 37413876 | Improving the turnaround time of molecular profiling for advanced non-small cell lung cancer: Outcome of a new algorithm integrating multiple approaches. | Pathol Res Pract | 2023 |
| 36779660 | Unravelling homologous recombination repair deficiency and therapeutic opportunities in soft tissue and bone sarcoma. | EMBO Mol Med | 2023 |
| 37088333 | Biallelic ELOC-Inactivated Renal Cell Carcinoma: Molecular Features Supporting Classification as a Distinct Entity. | Mod Pathol | 2023 |
| 36889303 | Utility of BAP1, p16, and Methylthio-Adenosine Phosphorylase Immunohistochemistry in Cytological and Histological Samples of Pleural Mesotheliomas. | Acta Cytol | 2023 |
| 37460872 | The Akt/mTOR and MNK/eIF4E pathways rewire the prostate cancer translatome to secrete HGF, SPP1 and BGN and recruit suppressive myeloid cells. | Nat Cancer | 2023 |
| 36759438 | A systematic comparison of pan-Trk immunohistochemistry assays among multiple cancer types. | Histopathology | 2023 |
| 37198015 | Epidemiology of Bladder Cancer in 2023: A Systematic Review of Risk Factors. | Eur Urol | 2023 |
| 36563965 | Cancer of unknown primary: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up. | Ann Oncol | 2023 |
| 36749655 | DNA Methylation Landscapes of Prostate Cancer Brain Metastasis Are Shaped by Early Driver Genetic Alterations. | Cancer Res | 2023 |
| 37123454 | CanIsoNet: a database to study the functional impact of isoform switching events in diseases. | Bioinform Adv | 2023 |
| 36999983 | Altered cytoplasmic and nuclear ADP-ribosylation levels analyzed with an improved ADP-ribose binder are a prognostic factor in renal cell carcinoma. | J Pathol Clin Res | 2023 |
| 36933996 | Ex Vivo Drug Testing in Patient-derived Papillary Renal Cancer Cells Reveals EGFR and the BCL2 Family as Therapeutic Targets. | Eur Urol Focus | 2023 |
| 36990278 | Analysis of the PARP1, ADP-Ribosylation, and TRIP12 Triad With Markers of Patient Outcome in Human Breast Cancer. | Mod Pathol | 2023 |
| 36921599 | Multiplex imaging of breast cancer lymph node metastases identifies prognostic single-cell populations independent of clinical classifiers. | Cell Rep Med | 2023 |
| 36975029 | [Pathology and Pathophysiology of BPH and Relevant Incidental Findings in TUR-P]. | Ther Umsch | 2023 |
| 37653120 | Multielement Z-tag imaging by X-ray fluorescence microscopy for next-generation multiplex imaging. | Nat Methods | 2023 |
| 37460872 | The Akt/mTOR and MNK/eIF4E pathways rewire the prostate cancer translatome to secrete HGF, SPP1 and BGN and recruit suppressive myeloid cells. | Nat Cancer | 2023 |
| 37123454 | CanIsoNet: a database to study the functional impact of isoform switching events in diseases. | Bioinform Adv | 2023 |
| 37088333 | Biallelic ELOC-Inactivated Renal Cell Carcinoma: Molecular Features Supporting Classification as a Distinct Entity. | Mod Pathol | 2023 |
| 36990278 | Analysis of the PARP1, ADP-Ribosylation, and TRIP12 Triad With Markers of Patient Outcome in Human Breast Cancer. | Mod Pathol | 2023 |
| 37413876 | Improving the turnaround time of molecular profiling for advanced non-small cell lung cancer: Outcome of a new algorithm integrating multiple approaches. | Pathol Res Pract | 2023 |
| 36975029 | [Pathology and Pathophysiology of BPH and Relevant Incidental Findings in TUR-P]. | Ther Umsch | 2023 |
| 36999983 | Altered cytoplasmic and nuclear ADP-ribosylation levels analyzed with an improved ADP-ribose binder are a prognostic factor in renal cell carcinoma. | J Pathol Clin Res | 2023 |
| 37198015 | Epidemiology of Bladder Cancer in 2023: A Systematic Review of Risk Factors. | Eur Urol | 2023 |
| 36889303 | Utility of BAP1, p16, and Methylthio-Adenosine Phosphorylase Immunohistochemistry in Cytological and Histological Samples of Pleural Mesotheliomas. | Acta Cytol | 2023 |
| 36921599 | Multiplex imaging of breast cancer lymph node metastases identifies prognostic single-cell populations independent of clinical classifiers. | Cell Rep Med | 2023 |
| 36749655 | DNA Methylation Landscapes of Prostate Cancer Brain Metastasis Are Shaped by Early Driver Genetic Alterations. | Cancer Res | 2023 |
| 36779660 | Unravelling homologous recombination repair deficiency and therapeutic opportunities in soft tissue and bone sarcoma. | EMBO Mol Med | 2023 |
| 36933996 | Ex Vivo Drug Testing in Patient-derived Papillary Renal Cancer Cells Reveals EGFR and the BCL2 Family as Therapeutic Targets. | Eur Urol Focus | 2023 |
| 36759438 | A systematic comparison of pan-Trk immunohistochemistry assays among multiple cancer types. | Histopathology | 2023 |
| 36563965 | Cancer of unknown primary: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up. | Ann Oncol | 2023 |
| 36202687 | Prostate Adenocarcinoma Grade Group 1: Rationale for Retaining a Cancer Label in the 2022 World Health Organization Classification. | Eur Urol | 2023 |
| 36198279 | Matrix-Assisted Laser Desorption/Ionization Mass Spectrometry Imaging: Diagnostic Pathways and Metabolites for Renal Tumor Entities. | Oncology | 2023 |
| 34331570 | Novel RGAG1-BCOR gene fusion revealed in a somatic soft tissue sarcoma with a long follow-up. | Virchows Arch | 2022 |
| 36109798 | A novel molecular signature identifies mixed subtypes in renal cell carcinoma with poor prognosis and independent response to immunotherapy. | Genome Med | 2022 |
| 35965208 | The 2022 World Health Organization Classification of Tumors of the Urinary System and Male Genital Organs-Part B: Prostate and Urinary Tract Tumors. | Eur Urol | 2022 |
| 36228153 | Vaccination with Designed Neopeptides Induces Intratumoral, Cross-reactive CD4+ T-cell Responses in Glioblastoma. | Clin Cancer Res | 2022 |
| 35758185 | WHO Classification of Tumours fifth edition: evolving issues in the classification, diagnosis, and prognostication of prostate cancer. | Histopathology | 2022 |
| 35504881 | Alterations in homologous recombination repair genes in prostate cancer brain metastases. | Nat Commun | 2022 |
| 35502823 | An introduction to the WHO 5th edition 2022 classification of testicular tumours. | Histopathology | 2022 |
| 36007219 | MTPpilot: An Interactive Software for Visualization of Next-Generation Sequencing Results in Molecular Tumor Boards. | JCO Clin Cancer Inform | 2022 |
| 35438203 | Morphological spectrum and molecular features of somatic malignant transformation in germ cell tumours. | Histopathology | 2022 |
| 36001976 | SF3B1 facilitates HIF1-signaling and promotes malignancy in pancreatic cancer. | Cell Rep | 2022 |
| 35629151 | Validation of a Novel Three-Dimensional (<i>3D Fusion</i>) Gross Sampling Protocol for Clear Cell Renal Cell Carcinoma to Overcome Intratumoral Heterogeneity: The Meet-Uro 18 Study. | J Pers Med | 2022 |
| 36212478 | Modified immunoscore improves the prediction of progression-free survival in patients with non-muscle-invasive bladder cancer: A digital pathology study. | Front Oncol | 2022 |